Showing 3901-3910 of 4063 results for "".
- Study: Vision Loss Has Significant Impact on Use of Hospital Resources and Costs for Older Patientshttps://modernod.com/news/study-vision-loss-has-significant-impact-on-use-of-hospital-resources-and-costs-for-older-patients/2476440/A national study has found that older patients with vision loss who are hospitalized for common disorders are often not identified as requiring special attention, which can affect outcomes, resource use, and costs. The study is published in the April 4 issue o
- Ocutrx Vision Technologies Receives Second Patent for Augmented Reality Glasses Eye Tracking Technologyhttps://modernod.com/news/ocutrx-vision-technologies-receives-second-patent-for-augmented-reality-glasses-eye-tracking-technology/2476434/Ocutrx Vision Technologies, a manufacturer of augmented reality (AR) glasses, announced the issuance of the company’s second US patent, which will protect the company’s unique eye tracking technology for patients with macular degeneration and other low vision conditions. The patent applies to bot
- Bausch + Lomb Announces US Launch of Lotemax SMhttps://modernod.com/news/bausch-lomb-announces-us-launch-of-lotemax-sm-0-38-for-treatment-of-postoperative-inflammation-and-pain/2476431/Bausch + Lomb announced it has launched Lotemax SM (loteprednol etabonate ophthalmic gel) 0.38%, indicated for the treatment of postoperative inflammation and pain following ocular surgery. The company received final approval by the FDA on February 22, 2019. Lotemax SM is a new gel drop fo
- Allergan and Molecular Partners Announce Topline Safety Results From MAPLE Study of Abicipar Pegolhttps://modernod.com/news/allergan-and-molecular-partners-announce-topline-safety-results-from-maple-study-of-abicipar-pegol/2476430/Allergan and Molecular Partners announced topline safety results from MAPLE, a 28-week open-label study which enrolled 123 age-related neovascular macular degeneration (AMD) patients and evaluated the safety of abicipar produced via a modified manufacturing process. In this single arm study, trea
- Iridex Provides Update on World Glaucoma Congress Activitieshttps://modernod.com/news/iridex-provides-update-on-world-glaucoma-congress-activities/2476427/Iridex announced that its Cyclo G6 glaucoma laser and proprietary MicroPulse Technology were featured in various posters and presentations at the World Glaucoma Congress last week in Melbourne, Australia. The congress ran from March 27- 31, 2019. Eight glaucoma specialists provided hands-o
- Arkansas Secures Expanded Scope of Practicehttps://modernod.com/news/arkansas-secures-expanded-scope-of-practice/2479581/As advocates nationwide work to advance optometry’s future-focused role in health care, Arkansas becomes the latest state enacting scope of practice expansion to include surgical procedures, according to the American Optometric Association. Signed into law March 27 by Gov. Asa Hutch
- Mary Lynch, MD, Receives Innovator Award from the American Glaucoma Societyhttps://modernod.com/news/mary-lynch-md-receives-innovator-award-from-the-american-glaucoma-society/2476419/The American Glaucoma Society has named Emory Eye Center ophthalmologist Mary G. Lynch, MD, as the 2019 recipient of the society’s prestigious Innovator Award. The award is given to one physician each year in recognition of his or her contributions to the field of glaucoma. She is the first woman
- Quantel Medical Receives FDA Approval for ABSolu Ultrasound Platformhttps://modernod.com/news/quantel-medical-receives-fda-approval-for-absolu-ultrasound-platform/2476415/Quantel Medical announced that it has received approval from the FDA for the new A/B/S ultrasound platform: ABSolu. The ABSolu includes a new 5 ring annular technology 20MHz B probe that increases the depth of
- Optovue Launches New AngioWellness Scan at Vision Expo Easthttps://modernod.com/news/optovue-launches-new-angiowellness-scan-at-vision-expo-east/2476399/Optovue will launch its new AngioWellness scan at Vision Expo East in New York, March 21-24, 2019. The AngioWellness scan utilizes Optovue’s advanced AngioVue OCTA technology to quickly assess and diagnose new pathologies in patients, including diabetic patients and those who may be at ris
- 5% People Tested Positive at Free Initial Screenings for Glaucoma at Saifee Hospitalhttps://modernod.com/news/5-people-tested-positive-at-free-initial-screenings-for-glaucoma-at-saifee-hospital/2476400/Saifee Hospital, one of Mumbai’s leading multi-specialty hospitals, conducted almost 400 free eye check-ups for their visitors to observe World Glaucoma Week. The check-ups were conducted throughout the week and more than 20 people were detected to have high